A New Database from the FDA: Inspections of Drug Manufacturing Facilities
Food and drug manufacturers’ inspection records and citations for misleading advertising will be disclosed by U.S. regulators as part of the Obama administration’s efforts to improve transparency in government.
The Food and Drug Administration released a database of inspections conducted from Oct. 1, 2008, to Sept. 30, 2010, and plans to update the list each fiscal year, according to Tamara Ward, an agency spokeswoman. The FDA will also start sharing more letters warning companies of illegal product promotions within the next six to nine months, she said.
The new database includes the name and address of the company being inspected, the purpose of the visit, the date the review ended and whether the findings prompted additional actions or referral to state or FDA officials.
Filed under: News
About Gary Price
Gary Price (firstname.lastname@example.org) is a librarian, writer, consultant, and frequent conference speaker based in the Washington D.C. metro area. He earned his MLIS degree from Wayne State University in Detroit. Price has won several awards including the SLA Innovations in Technology Award and Alumnus of the Year from the Wayne St. University Library and Information Science Program. From 2006-2009 he was Director of Online Information Services at Ask.com.